Business News • MarketWire • ContraFect Corporation Announces Fourth Quarter and Full Year 2014 Results |
ContraFect Corporation Announces Fourth Quarter and Full Year 2014 Results |
|
|
ContraFect Corporation Announces Fourth Quarter and Full Year 2014 Results
YONKERS, NY--(Marketwired - Apr 6, 2015) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant infectious diseases, today announced results for the fourth quarter and full year ended December 31, 2014. The Company closed its initial public offering (IPO) on August 1, 2014 and ended 2014 with cash, cash equivalents and marketable securities of $27.4 million versus $4.1 million at the close of 2013.
View More : http://www.marketwired.com/mw/release.do?id=2006722&sourceType=3
|
|
|